Editorial: The Foundation and Architecture of Personalized & Precision Medicine (PPM) in Clinical Autoimmunity Conditions: Towards Neurodegenerative Disease-Modifying Treatment

Sergey Suchkov¹˒²˒³˒⁴˒⁵˒⁶*, Roger D. Kamm¹⁰, Lidiya Kadyrova¹⁷, Daniel Scherman¹¹, Tatsuhiro Shibata¹³, Vladimir Zemskov¹⁶, Alan Spatz¹⁴, Valentina Demidova¹⁶, Shawn Murphy⁸˒⁹, Eric J. Sorenson¹², Vassiliy Tsytsarev¹⁵, and Trevor Marshall⁷

¹The Russian University of Medicine, Moscow, Russia
²The Russian Academy of Natural Sciences, Moscow, Russia
³EPMA, Brussels, EU
?PMC, Washington, DC, USA
?ISPM, Tokyo, Japan
?AHA, Houston, TX, USA
?Autoimmunity Research Foundation, Los Angeles, CA, USA
?MGH, Boston, MA, USA
?Harvard Medical School, Boston, USA
¹?MIT, Cambridge, USA
¹¹Faculté de Pharmacie, Université Paris Descarte, France
¹²Mayo Clinic, Rochester, MN, USA
¹³The Institute of Medical Science, University of Tokyo, Japan
¹?McGill University Health Center (MUHC) & McGill University Jewish General Hospital, QC Canada
¹?Department of Anatomy and Neurobiology, University of Maryland, College Park, MA, USA
¹?A.V. Vishnevsky National Medical Research Center for Surgery, Moscow, Russia
¹?Department of Neurophysiology of Kazan State Medical Academy, Russia

Corresponding Author:

Sergey Suchkov, The Russian University of Medicine, Moscow, Russia